Updates in Advanced Pancreatic Cancer: Integrating New Therapies Into Clinical Practice

CME: 1.0

August 17, 2021
/ Print / Reprints /
| Share More
/ Text Size+

Target Audience

This activity is designed to meet the educational needs of Oncology NPs, PAs, and nurses.

Program Overview

New treatments for advanced pancreatic cancer are leading to better outcomes and allowing patients to go on maintenance therapy. In this activity, an expert panel reviews recent clinical evidence and guideline-based selection of appropriate therapies. The case-based discussion covers germline and somatic testing for biomarkers, selection of first- and later-line agents, novel and emerging therapies, and management of disease-related symptoms and treatment-related adverse events. Use of an individualized approach and improving patient adherence and are also emphasized.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Summarize recent findings on the use of biomarkers in pancreatic cancer
  • Identify the appropriate use of newer therapies for pancreatic cancer based on efficacy and safety data and patient factors
  • Implement strategies to address treatment-related adverse events and promote adherence among patients with pancreatic cancer

Post a comment to this article